Search

  • HOME
  • Search
Review
1714
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.   Published online October 13, 2022
View: 1630   Download: 272  Citation: 1
Original Article
1688
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
Clin Mol Hepatol. 2022;28(4):827-840.   Published online June 22, 2022
View: 2413   Download: 195  Citations: 3
Editorial
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 953   Download: 38
Letter to the Editor
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online February 15, 2022
View: 2242   Download: 226  Citations: 3
Original Article
1642
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2022;28(1):77-90.   Published online November 5, 2021
View: 2799   Download: 101  Citations: 5
1607
Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
Lilian Yan Liang, Hye Won Lee, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip, Yee-Kit Tse, Vicki Wing-Ki Hui, Grace Chung-Yan Lui, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(3):499-509.   Published online February 26, 2021
View: 2663   Download: 128  Citations: 7
Review
1578
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada
Clin Mol Hepatol. 2021;27(3):413-424.   Published online December 3, 2020
View: 10023   Download: 412  Citations: 11
Original Article
1581
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol. 2021;27(2):295-304.   Published online December 3, 2020
View: 3448   Download: 180  Citations: 8
Editorial
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2021;27(2):273-277.   Published online February 1, 2021
View: 2722   Download: 114  Citations: 2
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
View: 2649   Download: 111  Citations: 2
Review
1563
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
View: 9186   Download: 309  Citations: 15
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696.   Published online September 28, 2020
View: 3933   Download: 177  Citations: 8
Review
1510
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada
Clin Mol Hepatol. 2020;26(3):280-293.   Published online June 4, 2020
View: 5258   Download: 203  Citations: 7
Original Article
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol. 2020;26(1):60-69.   Published online October 22, 2019
View: 4670   Download: 125  Citations: 3
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol. 2020;26(1):33-44.   Published online June 27, 2019
View: 4581   Download: 171  Citations: 12
Review
1449
Advances in ultrasound diagnosis in chronic liver diseases
Hitoshi Maruyama, Naoya Kato
Clin Mol Hepatol. 2019;25(2):160-167.   Published online February 18, 2019
View: 8735   Download: 417  Citations: 21
Original Article
1418
The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
Laura Rotundo, Alana Persaud, Mirela Feurdean, Sushil Ahlawat, Hyun-seok Kim
Clin Mol Hepatol. 2018;24(4):392-401.   Published online August 2, 2018
View: 10157   Download: 215  Citations: 26
Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases
San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón
Clin Mol Hepatol. 2018;24(4):384-391.   Published online July 4, 2018
View: 6321   Download: 189  Citations: 9
Editorial
Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
Mi Young Jeon, Beom Kyung Kim, Seung Up Kim
Clin Mol Hepatol. 2018;24(4):367-369.   Published online September 19, 2018
View: 5402   Download: 167  Citations: 4
Review
1401
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol. 2018;24(2):108-113.   Published online January 22, 2018
View: 10758   Download: 481  Citations: 28
1396
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol. 2017;23(4):302-307.   Published online December 20, 2017
View: 11812   Download: 449  Citations: 63
Liver Imaging
What we need to know when performing and interpreting US elastography
So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
Clin Mol Hepatol. 2016;22(3):406-414.   Published online September 25, 2016
View: 10714   Download: 265  Citations: 36
Original Article
1281
Magnetization-tagged MRI is a simple method for predicting liver fibrosis
Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna
Clin Mol Hepatol. 2016;22(1):140-145.   Published online March 28, 2016
View: 7268   Download: 69  Citation: 1
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon
Clin Mol Hepatol. 2015;21(2):141-149.   Published online June 26, 2015
View: 7659   Download: 123  Citations: 37
The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
Clin Mol Hepatol. 2015;21(1):32-40.   Published online March 25, 2015
View: 7932   Download: 78  Citations: 12
Editorial
Regression of liver cirrhosis: Orthodoxy or paradigm shift?
Su Jong Yu
Clin Mol Hepatol. 2015;21(1):22-23.   Published online March 25, 2015
View: 5551   Download: 80  Citation: 1
Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD
Wonseok Kang, Seung Up Kim
Clin Mol Hepatol. 2013;19(3):255-257.   Published online September 30, 2013
View: 4713   Download: 44  Citations: 2
Original Article
The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis
Jong Ho Chung, Hyung Su Ahn, Sang Gyune Kim, Yun Nah Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim
Clin Mol Hepatol. 2013;19(2):156-164.   Published online June 27, 2013
View: 8514   Download: 115  Citations: 28
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park
Clin Mol Hepatol. 2013;19(2):148-155.   Published online June 27, 2013
View: 6011   Download: 28  Citations: 2
Editorial
Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
Goh Eun Chung, Donghee Kim
Clin Mol Hepatol. 2013;19(2):116-119.   Published online June 27, 2013
View: 5830   Download: 87
1 | 2 | 3 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 590
TOTAL : 1132386
Close layer